Lutetium (177Lu) chloride
Lutetium (177Lu) chloride
Lutetium (177Lu) chloride is a radioactive compound used in nuclear medicine for radiotherapy and diagnostic imaging. It is composed of the isotope Lutetium-177 and chloride ions. This compound is particularly significant in the treatment of certain types of cancer, including neuroendocrine tumors and prostate cancer.
Properties
Lutetium-177 is a beta emitter with a half-life of approximately 6.65 days. It decays to stable Hafnium-177 through the emission of beta particles and gamma radiation. The beta particles are effective in destroying cancer cells, while the gamma radiation can be used for imaging purposes.
Applications
Lutetium (177Lu) chloride is primarily used in targeted radionuclide therapy. It is often conjugated with peptides or antibodies that specifically target cancer cells, allowing for precise delivery of radiation to the tumor site while minimizing damage to surrounding healthy tissue.
Neuroendocrine Tumors
One of the most common applications of Lutetium (177Lu) chloride is in the treatment of neuroendocrine tumors. These tumors can be targeted using peptide receptor radionuclide therapy (PRRT), where the compound is linked to a peptide that binds to receptors on the tumor cells.
Prostate Cancer
Lutetium (177Lu) chloride is also used in the treatment of prostate cancer, particularly in cases where the cancer has spread to other parts of the body. It is often linked to molecules that target prostate-specific membrane antigen (PSMA), a protein commonly found on prostate cancer cells.
Production
Lutetium-177 is typically produced in a nuclear reactor through the irradiation of Ytterbium-176 or Lutetium-176. The resulting Lutetium-177 is then chemically separated and combined with chloride ions to form Lutetium (177Lu) chloride.
Safety and Handling
As a radioactive substance, Lutetium (177Lu) chloride must be handled with care. Proper radiation protection measures, including the use of lead shielding and personal protective equipment, are essential to minimize exposure to radiation.
Related Pages
- Nuclear medicine
- Radiotherapy
- Neuroendocrine tumors
- Prostate cancer
- Peptide receptor radionuclide therapy
- Prostate-specific membrane antigen
- Beta emitter
- Gamma radiation
Categories
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
